Due to the anti-iron overload and antioxidant effects of ferritin, our study aims to confirm the effects of this new intervention on serum iron levels, atherosclerosis progression and plaque vulnerability in Apo-E(−/−) mice through the intraperitoneal administration of FT-H. This evidence concerns the gene APOE and atherosclerosis.